Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $119.49M.
ENTERPRISE VALUE (EV)
$119.49M
NRx Pharmaceuticals, Inc.
Market Cap
$127.29M
Enterprise Value (EV)
$119.49M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| NRx Pharmaceuticals, Inc. (NRXP) | $127.29M | $119.49M |
| Pyxis Oncology, Inc. (PYXS)vs › | $127.98M | $126.96M |
| Entera Bio Ltd. (ENTX)vs › | $124.70M | $113.82M |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | $123.59M |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | $240.18M |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | $182.86M |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | N/A |
| LifeMD, Inc. (LFMD)vs › | $132.03M | $112.91M |
| BGM Group Ltd. (BGM)vs › | $122.43M | $112.09M |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A |
Market Cap
$127.29M
Total Debt
$0.00
Cash
$7.80M
Enterprise Value
$119.49M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
